Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
This is a randomized, triple-blind, placebo-controlled, multicenter study to investigate the
safety of pramlintide treatment using pramlintide dose-titration coupled with insulin
adjustments in subjects with type 1 diabetes who are actively trying to improve their
glycemic control.